Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline have some experts expressing concern.

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly $50 copay.

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.

The proportion of adults in the US taking GLP-1 medications for weight loss has reached a record high of about 40 million people.

Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a ...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.

Starting this week, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called ...

The Trump administration's promised Medicare pilot program for GLP-1 weight-lossdrugs was positioned to help cover the costs of these medications, helpingseniors avoidwasting money in retirement while ...

Build muscle, boost your metabolism, and get stronger with this starter plan.

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.